🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors

Recruitingn/aAges 50 Years - anyAllTechnical University of Munich
NCT06796582 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 50 years * At least one of the following cardiovascular diseases / risk factors: * Heart failure * Coronary heart disease * Atrial fibrillation * Arterial hypertension * Type 2 diabetes mellitus * Clinically stable for ≥ 4 weeks * Medical clearance to perform resistance training / strength testing * Signed written informed consent Exclusion Criteria: * Pregnancy * Acute infection * Chronic joint inflammation * Knee, hip, ankle, wrist, elbow or shoulder pain * Known osteoporosis (T-value ≤ -2.5) * Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic) * Known cerebral or thoracic aneurysm
💊

What it tests

  • Not listed
📍

Where

1 site
Department for Preventive Sports Medicine and Sports Cardiology, TUM Klinikum Rechts der Isar, Technical University of Munich
München, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy